Comprehensive overview about ovarian cancer and secondary peritoneal tumors
Cianci, S.; Scambia, G.
Minerva Medica 110(4): 277-278
2019
ISSN/ISBN: 0026-4806 PMID: 31142098 Document Number: 698491
Document emailed within 1 workday
Related Documents
Carcione, R.; Gasparini, P.; Pasquinucci, C. 1987: Role of peritoneal cytology in the treatment of ovarian tumors: culdocentesis and closed peritoneal washing Annali di Ostetricia Ginecologia Medicina Perinatale 108(5): 307-315Strache, R.R.; Göcze, P.M.; Szábo, D.G.; Büttner, H.H.; Briese, V.; Kunze, M.; Csaba, I.F.; Röpcke, G. 1989: Placental protein 12 (PP 12) in cyst and peritoneal fluids and serum samples of patients with ovarian cysts and cystic ovarian tumors Zentralblatt für Gynakologie 111(11): 749-754
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Kunze, M.; Büttner, H.H.; Strache, R.R.; Voss, P.; Briese, V.; Schrodt, U. 1988: CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors Zentralblatt für Gynakologie 110(16): 1006-1012
Jin, Z.; Gu, J.; Xin, X.; Li, Y.; Wang, H. 2014: Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer European Journal of Gynaecological Oncology 35(5): 519-524
Jacobs, I.J.; Smith, S.A.; Wiseman, R.W.; Futreal, P.A.; Harrington, T.; Osborne, R.J.; Leech, V.; Molyneux, A.; Berchuck, A.; Ponder, B.A. 1993: A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus Cancer Research 53(6): 1218-1221
Briese, V.; Strache, R.R.; Voss, P.; Kunze, M.; Büttner, H.H. 1988: Protein studies in cystic and peritoneal fluids of ovarian tumors with special reference to CEA Zentralblatt für Gynakologie 110(5): 291-297
Studzinski, Z.; Zajewski, W. 2002: Bilateral metastatic ovarian tumors (Krukenberg's tumors) in the course of stomach cancer Archives of Gynecology and Obstetrics 267(2): 95-97
Prasad, G.R.; Dalal, A.V.; Tongaonkar, H.B.; Chatterjee, S.; Kamat, M.R. 1995: Do we need to do comprehensive surgical staging in all cases of clinical early ovarian cancer? Indian Journal of Cancer 32(2): 69-73
Paik, H.H.; Wilkinson, E.J. 1976: Peritoneal osteosarcoma following irradiation therapy of ovarian cancer Obstetrics and Gynecology 47(4): 488-491
Bagga, R.; Suri, V.; Malhotra, S.; Patel, Y. 2005: Peritoneal tuberculosis mimicking advanced ovarian cancer International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 90(3): 242-244
Gasowska-Bodnar, A.; Bodnar, L.; Wcisło, G.B.; Jerzak, M.łg.M.; Szczylik, C.; Baranowski, W.ło. 2008: CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction Ginekologia Polska 79(2): 108-114
Yonemura, Y.; Canbay, E.; Sako, S.; Wakama, S.; Ishibashi, H.; Hirano, M.; Mizumoto, A.; Takao, N.; Ichinose, M.; Noguchi, K.; Motoi, S.; Liu, Y.; Li, Y.; Taniguchi, K. 2017: Comprehensive Treatment Using Cytoreductive Surgery Combined with Perioperative Chemotherapy Improved Outcome of Colorectal Cancer Patients with Metachronous Peritoneal Metastasis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 1939-1942
Berek, J.S.; Bast, R.C.; Lichtenstein, A.; Hacker, N.F.; Spina, C.A.; Lagasse, L.D.; Knapp, R.C.; Zighelboim, J. 1984: Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer Obstetrics and Gynecology 64(5): 708-714
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Laganà, A.S.; Colonese, F.; Colonese, E.; Sofo, V.; Salmeri, F.M.; Granese, R.; Chiofalo, B.; Ciancimino, L.; Triolo, O. 2015: Cytogenetic analysis of epithelial ovarian cancer's stem cells: an overview on new diagnostic and therapeutic perspectives European Journal of Gynaecological Oncology 36(5): 495-505
Nowakowski, A.; Arbyn, M.; Turkot, M.H.; Wieszczy, P.; Miłosz, K.; Kamiński, Mł.F.; Didkowska, J.; Bidziński, M.; Olszewski, Włodzimierz.; Wielgoś, Mław.; Krzakowski, M.; Kuchar, E.; Walewski, J. 2020: A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 29(2): 157-164
Hu, X.Z. 1992: Detection of interferon-gamma in malignant peritoneal effusion in ovarian cancer patients Zhonghua Zhong Liu Za Zhi 14(4): 245-249
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Kitayama, R.; Nishizawa, M.; Tasaka, R.; Mita, I.; Tokuyama, O.; Miyama, M.; Kawamura, N. 2015: Transvaginal ultrasound-guided core needle biopsy for residual potentially malignant ovarian tumors in cases with severe peritoneal adhesion and frozen pelvis requiring polysurgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(5): 641-643